cGAS responds to cytosolic DNA by initiating a STING-dependent response that ultimately engages innate immune effectors to ensure the preservation of organismal homeostasis.
Perturbation
In physiological conditions, mammalian cells effectively degrade cytosolic DNA by nucleases, including three prime repair exonuclease 1 (TREX1) and ribonuclease H2 (RNase H2). However, various perturbations of cellular homeostasis can favor cytosolic DNA accumulation (especially when TREX1 or RNase H2 are defective), such as infection by DNA viruses, retroviruses, or intracellular prokaryotes; increased uptake of microenvironmental DNA (mainly via exosomes); phagocytosis of dead cells; mitochondrial damage; derepression of endogenous retroviruses; DNA damage (potentially linked to cellular senescence); and chromosomal instability (often associated with the formation of ruptureprone micronuclei).
Initiation
Cytosolic DNA can be transcribed by RNA polymerase III (RNA Pol III) to drive RIG-I signaling. Most often, however, cytosolic DNA is recognized by specialized sensors, including cyclic GMP-AMP synthase (cGAS). Active cGAS dimers condense ATP and GTP to synthesize cyclic [G(2′,5′)pA(3′,5′)p], a second messenger known as cyclic GMP-AMP (cGAMP). cGAMP activates transmembrane protein 173 (TMEM173, best known as STING), a protein of the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment (ERGIC). Other cyclic dinucleotides (CDNs) of bacterial origin, including cyclic-di-AMP and cyclic-di-GMP, can activate STING. Moreover, cGAMP can readily cross gap junctions to cause STING signaling in cells not experiencing cytosolic DNA accumulation upfront. Importantly, proteins other than cGAS can activate STING upon detection of cytosolic DNA.
Execution
cGAMP-stimulated STING dimerizes as it recruits (thus activating) at least three cellular components with kinase activity: TANK binding kinase 1 (TBK1), mitogen-activated protein kinase kinase kinase 14 (MAP3K14, best known as NIK), and the heterotrimer commonly known as IκB kinase (IKK). TBK1 phosphorylates interferon regulatory factor 3 (IRF3), enabling its dimerization and nuclear import. NIK phosphorylates conserved helix-loop-helix ubiquitous kinase (CHUK; best known as IKKα) dimers (not explicitly depicted), which in turn phosphorylate nuclear factor kappa B subunit 2 (NFKB2; also known as p100) complexed with RELB proto-oncogene, NF-kB subunit (RELB). Phosphorylated p100 is partially degraded by the proteasome, enabling p52/RELB heterodimers to elicit non-canonical NF-κB signaling. IKK phosphorylates NFKB inhibitor alpha (NFKBIA; best known as IκB) to promote IκB proteasomal degradation, thus enabling p50/p65 heterodimers to elicit canonical NF-κB signaling. Interferon beta 1 (IFNB1) is one of the main genes responding to STING-dependent IRF3 activation, resulting in abundant type-I interferon (IFN) secretion.
Regulation
Type-I IFN signaling via IFNAR1/IFNAR2 heterodimers activates tyrosine kinase 2 (TYK2) and Janus kinase 1 (JAK1). This enables the phosphorylation (P) of STAT1/STAT2 heterodimers, which culminates with the transactivation of multiple genes including CGAS (potentially establishing a feed-forward amplification loop). cGAS is inhibited upon AKT serine/threonine kinase 1 (AKT1)-dependent phosphorylation, as well as upon glutamylation (G) by tubulin tyrosine ligase like 4 (TTLL4) and TTLL6. This latter modification is antagonized by ATP/GTP binding protein-like 5 (AGBL5; best known as CCP5) and AGBL4 (best known as CCP6). Extracellular cGAMP can be hydrolyzed by ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), although the mechanism responsible for cGAMP secretion remains unknown. STING signaling is boosted upon K63-linked ubiquitination (U) by tripartite motif-containing 32 (TRIM32) and TRIM56, as well as upon K25-linked ubiquitination by the AMFR/INSIG1 heterodimer. Conversely, K47-linked ubiquitination by TRIM30a or ring finger protein 5 (RNF5) promotes proteasomal STING degradation. Multiple CDNs can also stimulate autophagic STING degradation via unc-51 like autophagy activating kinase 1 (ULK1).
Notes
The biological outcomes of cGAS-STING signaling, which encompass cell-intrinsic and cell-extrinsic processes, exhibit considerable heterogeneity. This reflects not only cell-intrinsic features, but also cell-extrinsic factors, including microenvironmental cues. In particular, the nature, intensity, and duration of the initiating trigger influences considerably the type and magnitude of the response. Thus, whereas acute, high-intensity cGAS-STING signaling triggered by fractionated radiation in cancer cells drives abundant type I IFN production (hence enabling systemic anticancer immunity), chronic, low-intensity cGAS-STING signaling caused by genomic instability promotes noncanonical NF-κB signaling (which fosters metastatic dissemination). Moreover, deregulated cGAS-STING signaling has been involved in autoimmune disorders and in pathological instances of maladaptation (e.g., heart failure). Despite these and other complexities, the molecular apparatus underlying cGAS-STING signaling and its regulators stand out as promising targets for the development of novel therapies against multiple diseases. ABBREVIATIONS AMFR, autocrine motility factor receptor; INSIG1, insulin induced gene 1; IFNAR, interferon (alpha and beta) receptor; p50 (official name, RELA), RELA proto-oncogene, NF-kB subunit; p65 (official name, NFKB1), nuclear factor kappa B subunit 1; RT, reverse transcriptase; STAT, signal transducer and activator of transcription; TRAF6, TNF receptor associated factor 6.
